Long-term tolerance to kidney allografts in a preclinical canine model

Transplantation

Volumn 84, Issue 4, 2007, Pages 545-547

  Kuhr, Christian S ^a,b   Yunusov, Murad ^a   Sale, George ^a,b   Loretz, Carol ^a,b   Storb, Rainer ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Canine; Kidney; Rejection; Tolerance; Transplantation

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; CONTROLLED STUDY; ENGRAFTMENT; FOLLOW UP; GRAFT REJECTION; HEMATOPOIETIC CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY FUNCTION; LOW ENERGY RADIATION; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; WHOLE BODY RADIATION;

ANIMALS; DOGS; GRAFT SURVIVAL; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; KIDNEY; KIDNEY TRANSPLANTATION; MODELS, ANIMAL; SKIN TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION TOLERANCE;

EID: 34548169143     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000270325.84036.52     Document Type: Article

References (15)

1. Kuhr CS, Allen MD, Junghanss C, et al. Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras. Transplantation 2002; 73: 1487.
2. Yu C, Storb R, Mathey B, et al. DLA-identical bone marrow grafts after low-dose total body irradiation: Effects of high-dose corticosteroids and cyclosporine on engraftment. Blood 1995; 86: 4376.
3. Storb R, Yu C, Wagner JL, et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 1997; 89: 3048.
4. Storb R, Yu C, Zaucha JM, et al. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. Blood 1999; 94: 2523.
5. McSweeney PA, Niederwieser D, Shizuru JA, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390.
6. Maris MB, Niederwieser D, Sandmaier BM, et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 2003; 102: 2021.
7. Storb R, Yu C, Barnett T, et al. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation. Blood 1999; 94: 1131.
8. Fuchimoto Y, Gleit ZL, Huang CA, et al. Skin-specific alloantigens in miniature swine. Transplantation 2001; 72: 122.
9. Steinmuller D. Skin allograft rejection by stable hematopoietic chimeras that accept organ allografts still is an enigma (letter). Transplantation 2001; 72: 8.
10. Steinmuller D, Tyler JD, David CS. Cell-mediated cytotoxicity to non-MHCalloantigens on mouse epidermal cells. I. H-2 restricted reactions among strains sharing the H-2k haplotype. J Immunol 1981; 126: 1747.
11. de Bueger M, Bakker A, van Rood JJ, Van der Woude F, Goulmy E. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol 1992; 149: 1788.
12. Hettiaratchy S, Melendy E, Randolph MA, et al. Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine. Transplantation 2004; 77: 514.
13. Billingham RE, Brent L. Quantitative studies on tissue transplantation immunity. IV. Induction of tolerance in newborn mice and studies on the phenomenon of runt disease. Philos Trans R Soc Lond B Biol Sci 1959; 242: 477.
14. Monaco AP, Morris PJ. Clinical Tolerance: The end of the beginning. Transplantation 2004; 77: 921.
15. n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting. Transplantation 1994; 58: 701.